Status: Phase 1
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Hypersensitivity; Hypersensitivity, Immediate Phase 1 ClinicalTrials
CONTENTS